Preparation, characterization, and antitumor properties of cis-PtCl2 complexes linked to anthraquinones through position number 2.
A new series of platinum-anthraquinone complexes of the type cis-PtLL'Cl2 [where L is the monodentate AQ-NH-(CH2)n-NH2 and L' = NH3 or LL' is the bidentate ligand AQ-NH-(CH2)n. NH-(CH2)2-NH2] in which the anthraquinone is linked to the diaminedichloroplatinum (II) moiety through position 2 was prepared and screened in vitro for antileukemic activity against P388 cells. All ligands were characterized by 1H and 13C NMR spectroscopy and all complexes by 195Pt NMR. The platinum complexes of anthraquinones which are modified in position 2 are significantly less potent than their analogs which are substituted in position 1. The activity of the complexes is either equal to or lower than the activity of the free ligands themselves. In the attempt to prepare AQ-NH-(CH2)4-NH-(CH2)2-NH2, a new compound, 2-(N-pyrrolidine)anthraquinone, was obtained and its structure was determined by x-ray crystallography. It crystallized in the monoclinic system in the space group P2(1)/c. The unit cell parameters are a = 9.595(1), b = 12.537(2), c = 11.461(1) A, beta = 94.14(2) degrees, V = 1375(1) A3, and z = 4.
Gibson
D
D
Department of Pharmaceutical Chemistry, School of Pharmacy, Hebrew University, Jerusalem, Israel.
Mansur
N
N
Gean
K F
KF
D000818:Animals; D000880:Anthraquinones / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D002945:Cisplatin; D018360:Crystallography, X-Ray; D004354:Drug Screening Assays, Antitumor; D007941:Leukemia P388 / Q000188:drug therapy; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D017671:Platinum Compounds / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D000880:Anthraquinones; D000970:Antineoplastic Agents; D017671:Platinum Compounds; D002945:Cisplatin